• Home

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Cardiac amyloidosis

• Overview
• Symptoms
• Treatment

Definition:

Cardiac amyloidosis is a disorder caused by deposits of an abnormal protein in the heart tissue, which make it hard for the heart to work properly.

Alternative Names:

Amyloidosis - cardiac; Primary cardiac amyloidosis - AL type; Secondary cardiac amyloidosis - AA type; Stiff heart syndrome; Senile amyloidosis; Amyloidosis - senile

Causes, incidence, and risk factors:

Amyloidosis is the accumulation of clumps of proteins called amyloids in body tissues and organs. The proteins slowly replace normal tissue. There are many forms of amyloidosis.

Cardiac amyloidosis usually occurs during primary amyloidosis, also called AL type amyloidosis. Primary amyloidosis is usually seen in persons with multiple myeloma , a type of cancer.

Cardiac amyloidosis, also called "stiff heart syndrome," occurs when amyloid deposits take the place of normal heart muscle. It is the most typical type of restrictive cardiomyopathy . Patients with cardiac amyloidosis may have changes in the way electrical signals move through the heart. This is called a conduction disturbance.

Secondary amyloidosis, also called AA type, rarely affects the heart. However, a subtype of secondary amyloidosis called senile amyloidosis involves the heart and blood vessels. Senile amyloidosis is caused by overproduction of a protein different from both the AA and AL types. Senile cardiac amyloidosis is becoming more common as the average age of the population increases.

Cardiac amyloidosis is more common in men than in women. The disease is rare in people under age 40.

References:

Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine , 7th ed. St. Louis, Mo: WB Saunders; 2005:1683-1685.

Arora S, Arora A, Makkar RP, Monga A. Stiff heart syndrome. CMAJ . 2003 Jun 24;168(13):1690-1.

Kholova I, Kautzner J. Current treatment in cardiac amyloidosis. Curr Treat Options Cardiovasc Med . 2006 Dec;8(6):468-73.

• Review Date: 1/17/2007
• Reviewed By: Larry A. Weinrauch, MD, Assistant Professor of Medicine, Harvard Medical School, and Private practice specializing in Cardiovascular Disease, Watertown, MA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.